Design and development of solid lipid nanoparticles of tazarotene for the treatment of psoriasis and acne: a quality by design approach

References

• Kolli SS, Pecone D, Pona A, et al. Topical retinoids in acne vulgaris: a systematic review. Am J Clin Dermatol. 2019;20:345–365.
   PubMed Web of Science ®Google Scholar
• Ridolfi DM, Marcato PD, Justo GZ, et al. Chitosan-solid lipid nanoparticles as carriers for topical delivery of tretinoin. Colloids Surf B Biointerfaces. 2012;93:36–40.
   PubMed Web of Science ®Google Scholar
• Gaikwad J, Sharma S, Hatware KV. Review on characteristics and analytical methods of tazarotene: an update. Crit Rev Anal Chem. 2020;50:90–96.
   PubMed Web of Science ®Google Scholar
• Kumar R, Singh A, Garg N. Acoustic cavitation assisted hot melt mixing technique for solid lipid nanoparticles formulation, characterization, and controlled delivery of poorly water soluble drugs. J Drug Deliv Sci Technol. 2019;54:101277.
   Web of Science ®Google Scholar
• Mukherjee S, Maity S, Ghosh B, et al. Assessment of the antidiabetic potentiality of glyburide loaded glyceryl monostearate solid lipid nanoparticles. J Drug Deliv Sci Technol. 2020;55:101451.
   Web of Science ®Google Scholar
• Mukherjee S, Ray S, Thakur R. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci. 2009;71:349.
   PubMed Web of Science ®Google Scholar
• Kammari R, Das NG, Das SK Nanoparticulate systems for therapeutic and diagnostic applications. Emerging Nanotechnologies for Diagnostics, Drug Delivery and Medical Devices; Elsevier, 2017; pp. 105–144.
   Google Scholar
• Choi MJ, Maibach HI. Liposomes and niosomes as topical drug delivery systems. Skin Pharmacol Physiol. 2005;18:209–219.
   PubMed Web of Science ®Google Scholar
• Dinh HTT, Tran PHL, Duan W, et al. Nano-sized solid dispersions based on hydrophobic-hydrophilic conjugates for dissolution enhancement of poorly water-soluble drugs. Int J Pharm. 2017;533:93–98.
   PubMed Web of Science ®Google Scholar
• Tran TTD; Tran PHL. Nanoconjugation and encapsulation strategies for improving drug delivery and therapeutic efficacy of poorly water-soluble drugs. Pharmaceutics. 2019;11:325.
   Web of Science ®Google Scholar
• Wissing SA, Müller RH. The influence of solid lipid nanoparticles on skin hydration and viscoelasticity – in vivo study. Eur J Pharm Biopharm. 2003;56:67–72.
   PubMed Web of Science ®Google Scholar
• Teeranachaideekul V, Souto EB, Junyaprasert VB, et al. Cetyl palmitate-based NLC for topical delivery of coenzyme Q10 – development, physicochemical characterization and in vitro release studies. Eur J Pharm Biopharm. 2007;67:141–148.
   PubMed Web of Science ®Google Scholar
• Le NDT, Tran PHL, Lee B-J, et al. Solid lipid particle-based tablets for buccal delivery: the role of solid lipid particles in drug release. J Drug Deliv Sci Technol. 2019;52:96–102.
   Web of Science ®Google Scholar
• Pham DTT, Tran PHL, Tran TTD. Development of solid dispersion lipid nanoparticles for improving skin delivery. Saudi Pharm J. 2019;27:1019–1024.
   PubMed Web of Science ®Google Scholar
• The international council for harmonisation of technical requirements for pharmaceuticals for human use. Requirements for registration of pharmaceuticals for human use - guidelines for elemental impurities. ICH Harmon Tripart Guidel Pharm Dev Q8. 2009;8:24.
   Google Scholar
• Benner N, Sammons D. Overview of the treatment of acne vulgaris. Osteopath. Fam. Physician. 2013;5:185–190.
   Google Scholar
• Aggarwal G, Nagpal M, Kaur G. Development and comparison of nanosponge and niosome based gel for the topical delivery of tazarotene. Pharm Nanotechnol. 2016;4:213–228. .
   PubMedGoogle Scholar
• Bhalekar M, Upadhaya P, Madgulkar A. Formulation and characterization of solid lipid nanoparticles for an anti-retroviral drug darunavir. Appl Nanosci. 2017;7:47–57.
   Web of Science ®Google Scholar
• Pandey SS, Patel MA, Desai DT, et al. Bioavailability enhancement of repaglinide from transdermally applied nanostructured lipid carrier gel: optimization, in vitro and in vivo studies. J Drug Deliv Sci Technol. 101731;2020(57). DOI:https://doi.org/10.1016/j.jddst.2020.101731
   Google Scholar
• Patil KD, Bagade SB, Bonde SC. In-vitro and ex-vivo characterization of novel mannosylated gelatin nanoparticles of linezolid by quality-by-design approach. J Drug Deliv Sci Technol. 101976;2020(60). DOI:https://doi.org/10.1016/j.jddst.2020.101976
   Google Scholar
• Shangguan M, Qi J, Lu Y, et al. Comparison of the oral bioavailability of silymarin-loaded lipid nanoparticles with their artificial lipolysate counterparts: implications on the contribution of integral structure. Int J Pharm. 2015;489:195–202.
   PubMed Web of Science ®Google Scholar
• Cirri M, Mennini N, Maestrelli F, et al. Development and in vivo evaluation of an innovative “Hydrochlorothiazide-in cyclodextrins-in solid lipid nanoparticles” Formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics. Int J Pharm. 2017;521:73–83.
   PubMed Web of Science ®Google Scholar
• Aman RM, Abu Hashim II, Meshali MM. Novel chitosan-based solid-lipid nanoparticles to enhance the bio-residence of the miraculous phytochemical “apocynin. Eur J Pharm Sci. 2018;124:304–318.
   PubMed Web of Science ®Google Scholar
• Mohammadi-Samani S, Zojaji S, Entezar-Almahdi E. Piroxicam loaded solid lipid nanoparticles for topical delivery: preparation, characterization and in vitro permeation assessment. J Drug Deliv Sci Technol. 2018;47:427–433.
   Web of Science ®Google Scholar
• Din FU, Zeb A, Shah KU, et al. Development, in-vitro and in-vivo evaluation of ezetimibe-loaded solid lipid nanoparticles and their comparison with marketed product. J Drug Deliv Sci Technol. 2019;51:583–590.
   Web of Science ®Google Scholar
• Gonçalves LMD, Maestrelli F, Mannelli DC, et al. Development of solid lipid nanoparticles as carriers for improving oral bioavailability of glibenclamide. Eur J Pharm Biopharm. 2016;102:41–50.
   PubMed Web of Science ®Google Scholar
• Kumar S, Narayan R, Ahammed V, et al. Development of ritonavir solid lipid nanoparticles by Box Behnken design for intestinal lymphatic targeting. J Drug Deliv Sci Technol. 2018;44:181–189.
   Web of Science ®Google Scholar
• Meola TR, Schultz HB, Peressin KF, et al. Enhancing the oral bioavailability of simvastatin with silica-lipid hybrid particles: the effect of supersaturation and silica geometry. Eur J Pharm Sci. 2020;150:105357.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li Z, Zhang K, et al. Ethyl oleate-containing nanostructured lipid carriers improve oral bioavailability of trans -ferulic acid as compared with conventional solid lipid nanoparticles. Int J Pharm. 2016;511:57–64.
   PubMed Web of Science ®Google Scholar
• Rostamkalaei SS, Akbari J, Saeedi M, et al. Topical gel of metformin solid lipid nanoparticles: a hopeful promise as a dermal delivery system. Colloids Surf B Biointerfaces. 2019;175:150–157.
   PubMed Web of Science ®Google Scholar
• Abdel Hady M, Sayed OM, Akl MA. Brain uptake and accumulation of new levofloxacin-doxycycline combination through the use of solid lipid nanoparticles: formulation; optimization and in-vivo evaluation. Colloids Surf B Biointerfaces. 2020;193:111076.
   PubMed Web of Science ®Google Scholar
• Wang L, Wang C-Y, Zhang Y, et al. Preparation and characterization of solid lipid nanoparticles loaded with salmon calcitonin phospholipid complex. J Drug Deliv Sci Technol. 2019;52:838–845.
   Web of Science ®Google Scholar
• Kaur R, Sharma N, Tikoo K, et al. Development of mirtazapine loaded solid lipid nanoparticles for topical delivery: optimization, characterization and cytotoxicity evaluation. Int J Pharm. 2020;586:119439.
   PubMed Web of Science ®Google Scholar